Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
5-day change
1st Jan Change
11.4
CNY
+10.04%
+14.00%
-4.92%
Innovo Therapeutics announced that it has received CNY 100 million in funding from Qiandao Investment Fund Management Co., Ltd., Hainan Longmen Private Equity Fund Management Partnership (Limited Partnership), China Financial Strategy Investment Holdings Co., Ltd, Ming Bioventures, Zhuhai Huajin Capital Co., Ltd.
Innovo Therapeutics announced that it has raised nearly CNY 100 million in a round of funding led by new investor, Zhuhai Huajin Capital Co., Ltd. on December 1, 2023. The transaction included participation from new investor, Qiandao Investment Fund Management (Beijing) Co., Ltd., Hainan Longmen Private Equity Fund Management Partnership (Limited Partnership), China Financial Strategy Investment Holdings Co., Ltd and returning investor, Ming Bioventures.
Zhuhai Huajin Capital Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 25
CI
Zhuhai Huajin Capital Co., Ltd. Announces Profit Distribution Proposal for 2023
Mar. 26
CI
Zhuhai Huajin Capital Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 26
CI
Henan Medinno Pharmaceutical Technology Co., Ltd. announced that it has received funding from Zhuhai Huajin Capital Co., Ltd., Shenzhen Zhongjince Investment Co., Ltd.
Jan. 15
CI
Innovo Therapeutics announced that it has received CNY 100 million in funding from Qiandao Investment Fund Management Co., Ltd., Hainan Longmen Private Equity Fund Management Partnership (Limited Partnership), China Financial Strategy Investment Holdings Co., Ltd, Ming Bioventures, Zhuhai Huajin Capital Co., Ltd.
Nov. 30
CI
Zhuhai Huajin Capital Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-30
CI
Fujian Huaqing Electronic Material Technology Co., Ltd. announced that it has received funding from Shanghai Shangqi Investment Management Partnership Enterprise (Limited Partnership), SAIC Group Strategic Direct Investment Fund, China Automobile Capital Holding Co., Ltd., Oriza Houwang Investment Management Co., Ltd., Zhengqi Capital Holdings Limited, Zhuhai Huajin Capital Co., Ltd.
23-10-23
CI
Zhuhai Huajin Capital Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-24
CI
Zhuhai Huajin Capital Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 08 June 2023
23-06-01
CI
Zhuhai Huajin Capital Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-25
CI
Zhuhai Huajin Capital Co., Ltd. Approves Cash Dividend for the Year of 2022
23-04-14
CI
Zhuhai Huajin Capital to Form 6.3 Million Yuan Solar Rooftop JV
23-03-24
MT
Zhuhai Huajin Capital Co., Ltd. Announces Profit Distribution Proposal for 2022
23-03-23
CI
Hygea Medical Technology Co. Ltd. announced that it has received $29.5 million in funding from Hangzhou Yingdong Investment Management Co., Ltd., Banyan Pacific Capital and other investors
23-02-14
CI
Beijing Haawking Technology Co., Ltd. announced that it has received $14.4 million in funding from Sequoia China Investment Management LLP, Unity Ventures, Zhuhai Huajin Capital Co., Ltd., Skyworth Group, Investment Arm, Ginlong Technologies Co., Ltd., Shenzhen Skyworth Investment Management Enterprise (Limited Partnership)
22-12-22
CI
Zhuhai Huafa Urban Research Institute Co., Ltd. and Zhuhai Huafa Entity Industry Research Institute Co., Ltd. agreed to acquire 20% of stake in Zhuhai Huafa New Technology Investment Holding Co., Ltd from Zhuhai Huajin Capital Co., Ltd. for CNY 22 million.
22-11-28
CI
Zhuhai Huajin Capital Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-27
CI
Shenzhen Vivolight Medical Equipment Technology Co., Ltd. announced that it has received CNY 100 million in funding from Shanghai FOSUN Pharmaceutical Co., Ltd., Investment Arm, Sequoia China Investment Management LLP, Xi'an CAS Star Technology Incubator Co., Ltd., Zhuhai Huajin Capital Co., Ltd., Taihe Capital
22-09-15
CI
Zhuhai Huafa Entity Industrial Investment Holdings Co., Ltd. agreed to acquire a 33.02% stake in Zhuhai Higrand Technology Co.,Ltd from Zhuhai Huajin Capital Co., Ltd. for approximately CNY 130 million.
22-09-14
CI
Zhuhai Huajin Capital Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-25
CI
Zhuhai Huajin Capital Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 10, 2022
22-06-02
CI
Zhuhai Huajin Capital Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-04-26
CI
Zhuhai Huajin Capital Co., Ltd. Approves Cash Dividend for 2021
22-04-18
CI
Zhuhai Huajin Capital Maintains Final Dividend on Stellar 2021 Earnings
22-03-24
MT
Zhuhai Huajin Capital Co., Ltd. Proposes Profit Distribution for 2021
22-03-24
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Zhuhai Huajin Capital Co. Ltd. specializes in the design, manufacturing and marketing of electronic products. The products include electrolytic capacitors, cabling products, electronic components, software, etc. The group also proposes technologic and computing services (network engineering, training, software development services, etc.) and develops a power production activity.
China accounts for 94.7% of net sales.
More about the company
1st Jan change
Capi.
-4.92% 542M -6.44% 88.47B +15.32% 84.55B +12.36% 26.01B -6.65% 17.28B +6.74% 14.28B -16.11% 13.16B +16.00% 9.52B +26.11% 8.75B +27.22% 7.13B
Investment Management
Stock Market Equities 000532 Stock
News Zhuhai Huajin Capital Co., Ltd. Innovo Therapeutics announced that it has received CNY 100 million in funding from Qiandao Investment Fund Management Co., Ltd., Hainan Longmen Private Equity Fund Management Partnership (Limited Partnership), China Financial Strategy Investment Holdings Co., Ltd, Ming Bioventures, Zhuhai Huajin Capital Co., Ltd.
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
ZHUHAI HUAJIN CAPITAL CO., LTD. 
